1016457

Kadmon Pharmaceuticals, LLC — FEI 3009630500

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warrendale, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)